DarioHealth Corp Stock News

After starting its B2B2C program last year, DarioHealth should finally start to see organic growth in revenues as the company starts to implement its solutions within a large health plan. The company

State Street Corp acquired a new stake in shares of DarioHealth Corp. (NASDAQ:DRIO) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 200,990 shares of the companys stock, valued at approximately $4,293,000. State Street Corp owned about 1.29% of DarioHealth as [] The post State Street Corp Acquires Shares of 200,990 DarioHealth Corp. (NASDAQ:DRIO) appeared first on ETF Daily News .

State Street Corp purchased a new position in DarioHealth Corp. (NASDAQ:DRIO) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 200,990 shares of the companys stock, valued at approximately $4,293,000. State Street Corp owned about 1.29% of DarioHealth at the end of [] The post State Street Corp Invests $4.29 Million in DarioHealth Corp. (NASDAQ:DRIO) appeared first on ETF Daily News .

Nuveen Asset Management LLC bought a new position in DarioHealth Corp. (NASDAQ:DRIO) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 50,137 shares of the companys stock, valued at approximately $1,071,000. Nuveen Asset Management LLC owned approximately 0.32% of DarioHealth as of []

DarioHealth (NASDAQ:DRIO) issued its quarterly earnings results on Sunday. The company reported ($1.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters consensus estimate of ($0.94) by ($0.24), MarketWatch Earnings reports. DarioHealth had a negative net margin of 377.14% and a negative return on equity of 66.69%. During the same period in the []

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q3 2021 Results - Earnings Call Transcript

Equities research analysts expect DarioHealth Corp. (NASDAQ:DRIO) to post $5.95 million in sales for the current quarter, according to Zacks. Two analysts have made estimates for DarioHealths earnings. The highest sales estimate is $6.10 million and the lowest is $5.80 million. DarioHealth reported sales of $2.04 million in the same quarter last year, which indicates []

DarioHealth (NASDAQ:DRIO) reported its Q3 earnings results on Monday, November 15, 2021 at 04:30 PM. Here's what investors need to know about the announcement.

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences. Among the

DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.

NEW YORK, Nov. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the third quart

NEW YORK, Nov. 5, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate at the following conferen